Download PDF
Semin Liver Dis 2000; 20(4): 481-496
DOI: 10.1055/s-2000-13157
Copyright © 2000 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Recurrent Primary Biliary Cirrhosis, Primary Sclerosing Cholangitis, and Autoimmune Hepatitis after Transplantation

Thomas W. Faust
  • Liver Study Unit, Section of Gastroenterology, Department of Medicine, The University of Chicago Hospitals and Clinics, The University of Chicago, Chicago, Illinois
Further Information

Publication History

Publication Date:
31 December 2000 (online)

    Permissions and Reprints

ABSTRACT

Viral hepatitis and malignancy frequently recur after transplantation, but recurrence of primary biliary cirrhosis (PBC), primary sclerosing cholangitis (PSC), and autoimmune hepatitis is controversial. Differences in study design, number of patients, immunosuppressive treatment, length of follow-up, and criteria for recurrence account for discrepant results. Most patients with suspected recurrent disease are asymptomatic after transplantation. In patients transplanted for PBC, antimitochondrial antibodies frequently persist and do not correlate with disease recurrence; liver biopsy remains the gold standard for diagnosis. Exclusion of other disorders that can mimic PBC is paramount prior to making a diagnosis of recurrent disease. The effects of immunosuppression may modify or delay disease expression within the graft. If PBC recurs, intermediate-term patient and graft survival is excellent, but long-term studies will be necessary to address the impact of disease recurrence on the allograft. Due to lack of a diagnostic gold standard, a diagnosis of recurrent PSC after transplantation is difficult to make. An accurate diagnosis of PSC recurrence requires well-defined cholangiographic and histologic criteria. Other disorders that can produce biliary strictures after transplantation should be excluded. As with PBC, the effects of immunosuppression may modify or delay disease expression within the graft; medium-term patient and graft survival is excellent. Recurrence of autoimmune hepatitis is based on clinical, biochemical, serologic, and histologic criteria. As in patients transplanted for PBC and PSC, other conditions that can mimic autoimmune hepatitis require exclusion prior to making a diagnosis of recurrence. Most adult recipients respond to an increase in immunosuppression, whereas pediatric recipients do not respond as well. A cautious approach to withdrawal of immunosuppression is warranted in all patients transplanted for autoimmune hepatitis and the consequences of recurrent disease within the graft will require prolonged follow-up. Future studies should focus on preventive and therapeutic strategies for recurrent autoimmune diseases after transplantation.

KEYWORD

recurrent - disease - transplantation

REFERENCES

  • 1 Lee Y-M, Kaplan M M. Primary biliary cirrhosis. In: Friedman LS, Keefe EB, eds. Handbook of Liver Disease 1st ed. Edinburgh: Churchill Livingstone 1998: 197-214
    Search in Google Scholar
  • 2 Van de Water J, Turchany J, Leung P SL. Molecular mimicry in primary biliary cirrhosis. Evidence for biliary epithelial expression of a molecule cross-reactive with pyruvate dehydrogenase complex-E2.  J Clin Invest . 1993;  91 2653-2664
    PubMedSearch in Google Scholar
  • 3 Scheuer P J, Lefkowitch J H. Primary biliary cirrhosis. In: Scheuer PJ, Lefkowitch JH, eds. Liver Biopsy Interpretation fifth ed. London: WB Saunders 1994: 51-58
    Search in Google Scholar
  • 4 Batts K P, Wang X. Recurrence of primary biliary cirrhosis, autoimmune cholangitis and primary sclerosing cholangitis after liver transplantation.  Clin Liver Dis . 1998;  2 421-435
    PubMedSearch in Google Scholar
  • 5 Neuberger J, Portmann B, Macdougall B RD. Recurrence of primary biliary cirrhosis after liver transplantation.  N Engl J Med . 1982;  306 1-4
    CrossrefPubMedSearch in Google Scholar
  • 6 Polson R J, Portmann B, Neuberger J. Evidence for disease recurrence after liver transplantation for primary biliary cirrhosis. Clinical and histologic follow-up studies.  Gastroenterology . 1989;  97 715-725
    PubMedSearch in Google Scholar
  • 7 Dietze O, Margreiter R. Primary biliary cirrhosis (PBC) after liver transplantation.  Transpl Proc . 1990;  22 1501-1502
    PubMedSearch in Google Scholar
  • 8 Hubscher S G, Elias E, Buckels J AC. Primary biliary cirrhosis. Histological evidence of disease recurrence after liver transplantation.  J Hepatol . 1993;  18 173-184
    CrossrefPubMedSearch in Google Scholar
  • 9 Balan V, Batts K P, Porayko M K. Histological evidence for recurrence of primary biliary cirrhosis after liver transplantation.  Hepatology . 1993;  18 1392-1398
    CrossrefPubMedSearch in Google Scholar
  • 10 Sebagh M, Farges O, Dubel L. Histological features predictive of recurrence of primary biliary cirrhosis after liver transplantation.  Transplantation . 1998;  65 1328-1333
    CrossrefPubMedSearch in Google Scholar
  • 11 Van De Water J, Gerson L B, Ferrell L D. Immunohistochemical evidence of disease recurrence after liver transplantation for primary biliary cirrhosis.  Hepatology . 1996;  24 1079-1084
    PubMedSearch in Google Scholar
  • 12 Kim W R, Poterucha J J, Jorgensen R A. Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis?.  <~>Outcomes of ursodeoxycholic acid therapy and liver transplantation. Hepatology . 1997;  26 22-26
    PubMedSearch in Google Scholar
  • 13 Wong P YN, Portmann B, O'Grady J G. Recurrence of primary biliary cirrhosis after liver transplantation following fk506-based immunosuppression.  J Hepatol . 1993;  17 284-287
    CrossrefPubMedSearch in Google Scholar
  • 14 Dmitrewski J, Hubscher S G, Mayer A D, Neuberger J M. Recurrence of primary biliary cirrhosis in the liver allograft: the effect of immunosuppression.  Hepatology . 1996;  24 253-257
    PubMedSearch in Google Scholar
  • 15 Mazariegos G V, Reyes J, Marino I R. Weaning of immunosuppression in liver transplant recipients.  Transplantation . 1997;  63 243-249
    CrossrefPubMedSearch in Google Scholar
  • 16 Slapak G I, Saxena R, Portmann B. Graft and systemic disease in long-term survivors of liver transplantation.  Hepatology . 1997;  25 195-202
    CrossrefPubMedSearch in Google Scholar
  • 17 Haagsma E B, Manns M, Klein R. Subtypes of antimitochondrial antibodies in primary biliary cirrhosis before and after orthotopic liver transplantation.  Hepatology . 1987;  7 129-133
    PubMedSearch in Google Scholar
  • 18 Klein R, Huizenga J R, Gips C H, Berg P A. Antimitochondrial antibody profiles in patients with primary biliary cirrhosis before orthotopic liver transplantation and titres of antimitochondrial antibody-subtypes after transplantation.  J Hepatol . 1994;  20 181-189
    CrossrefPubMedSearch in Google Scholar
  • 19 Demetris A J, Markus B H, Esquival C. Pathologic analysis of liver transplantation or primary biliary cirrhosis.  Hepatology . 1988;  8 939-947
    PubMedSearch in Google Scholar
  • 20 Esquivel C O, Van Thiel H D, Demetris A J. Transplantation for primary biliary osis.  Gastroenterology . 1988;  94 1207-1216
    PubMedSearch in Google Scholar
  • 21 Buist L J, Hubscher S G, Vickers C. Does liver transplantation cure primary biliary cirrhosis?.  Transpl Proc . 1989;  21 2402
    PubMedSearch in Google Scholar
  • 22 Samuel D, Gugenheim J, Mentha G. Liver transplantation for primary biliary cirrhosis.  Transpl Proc . 1990;  22 1497-1498
    PubMedSearch in Google Scholar
  • 23 Gouw A SH, Haagsma E B, Manns M. Is there recurrence of primary biliary cirrhosis after transplantation?.  <~>A clinicopathologic study in long-term survivors. J Hepatol . 1994;  20 500-507
    CrossrefPubMedSearch in Google Scholar
  • 24 Luettig B, Boeker K HW, Schoessler W. The antinuclear antibodies Sp100 and gp210 persist after orthotopic liver transplantation in patients with primary biliary cirrhosis.  J Hepatol . 1998;  28 824-828
    CrossrefPubMedSearch in Google Scholar
  • 25 Dubel L, Farges O, Bismuth H. Kinetics of anti-M2 antibodies after liver transplantation for primary biliary cirrhosis.  Hepatology . 1995;  23 674-680
    PubMedSearch in Google Scholar
  • 26 Dubel L, Farges O, Courvalin J-C. Persistence of gp210 and multiple nuclear dots antibodies does not correlate with recurrence of primary biliary cirrhosis 6 years after liver transplantation.  J Hepatol . 1998;  28 169-170
    PubMedSearch in Google Scholar
  • 27 Ferrell L D, Lee R, Brixko C. Hepatic granulomas following liver transplantation.  Transplantation . 1995;  60 926-933
    PubMedSearch in Google Scholar
  • 28 Wiesner R H. Primary sclerosing cholangitis. In: Friedman LS, Keeffe EB, eds. Handbook of Liver Disease 1st ed. Edinburgh: Churchill Livingstone 1998: 215-225
    Search in Google Scholar
  • 29 Sebagh M, Farges O, Kalil A. Sclerosing cholangitis following human orthotopic liver transplantation.  Am J Surg Pathol . 1995;  19 81-90
    CrossrefPubMedSearch in Google Scholar
  • 30 McDonald V, Matalon T AS, Patel S. Biliary strictures in hepatic transplantation.  J Vasc Interv Radiol . 1991;  2 533-538
    CrossrefPubMedSearch in Google Scholar
  • 31 Harrison R F, Davies M H, Neuberger J M, Hubscher S G. Fibrous and obliterative cholangitis in liver allografts: evidence of recurrent primary sclerosing cholangitis?.  Hepatology . 1994;  20 356-361
    CrossrefPubMedSearch in Google Scholar
  • 32 Sheng R, Zajko A B, Campbell W L, Abu-Elmagd K. Biliary strictures in hepatic transplants: prevalence and types in patients with primary sclerosing cholangitis vs. those with other liver diseases.  Am J Roentgenol . 1993;  161 297-300
    PubMedSearch in Google Scholar
  • 33 Campbell W L, Sheng R, Zajko A B. Intrahepatic biliary strictures after liver transplantation.  Radiology . 1994;  191 735-740
    PubMedSearch in Google Scholar
  • 34 Sheng R, Campbell W L, Zajko A B, Baron R L. Cholangiographic features of biliary strictures after liver transplantation for primary sclerosing cholangitis: evidence of recurrent disease.  Am J Roentgenol . 1996;  166 1109-1113
    PubMedSearch in Google Scholar
  • 35 Narumi S, Roberts J P, Emond J C. Liver transplantation for sclerosing cholangitis.  Hepatology . 1995;  22 451-457
    CrossrefPubMedSearch in Google Scholar
  • 36 Feller R B, Waugh R C, Selby W S. Biliary strictures after liver transplantation: clinical picture, correlates and outcomes.  J Gastroenterol Hepatol . 1996;  11 21-25
    PubMedSearch in Google Scholar
  • 37 Goss J A, Shackleton C R, Farmer D G. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.  Ann Surg . 1997;  225 472-483
    CrossrefPubMedSearch in Google Scholar
  • 38 Jeyarajah D R, Netto G J, Lee S P. Recurrent primary sclerosing cholangitis after orthotopic liver transplantation.  Transplantation . 1998;  66 1300-1306
    PubMedSearch in Google Scholar
  • 39 Kita Y, Lake J R, Ferrell L D. Possible recurrence of primary sclerosing cholangitis following living-related liver transplantation: report of a case.  Transpl Proc . 1998;  30 3321-3323
    PubMedSearch in Google Scholar
  • 40 Saldeen K, Friman S, Olausson M, Olsson R. Follow-up after liver transplantation for primary sclerosing cholangitis: effects on survival, quality of life, and colitis.  Scand J Gastroenterol . 1999;  34 535-540
    CrossrefPubMedSearch in Google Scholar
  • 41 Graziadei I W, Wiesner R H, Batts K P. Recurrence of primary sclerosing cholangitis following liver transplantation.  Hepatology . 1999;  29 1050-1056
    CrossrefPubMedSearch in Google Scholar
  • 42 Marsh J W, Iwatsuki S, Makowka L. Orthotopic liver transplantation for primary sclerosing cholangitis.  Ann Surg . 1988;  207 21-25
    PubMedSearch in Google Scholar
  • 43 Letourneau J G, Day D L, Hunter D W. Biliary complications after liver transplantation in patients with preexisting sclerosing cholangitis.  Radiology . 1988;  167 349-351
    PubMedSearch in Google Scholar
  • 44 Lerut J, Demetris A J, Stieber A C. Intrahepatic bile duct strictures after human orthotopic liver transplantation.  Transpl Int . 1988;  1 127-130
    CrossrefPubMedSearch in Google Scholar
  • 45 Ward E M, Kiely M J, Maus T P. Hilar biliary strictures after liver transplantation: cholangiography and percutaneous treatment.  Radiology . 1990;  177 259-263
    PubMedSearch in Google Scholar
  • 46 Haagsma E B, Mulder A HL, Gouw A SH. Neutrophil cytoplasmic autoantibodies after liver transplantation in patients with primary sclerosing cholangitis.  J Hepatol . 1993;  19 8-14
    CrossrefPubMedSearch in Google Scholar
  • 47 Davern T J, Lake J R. Recurrent disease after liver transplantation.  Semin Gastrointest Dis . 1998;  9 86-109
    PubMedSearch in Google Scholar
  • 48 Czaja A. Autoimmune hepatitis. In: Friedman LS, Keefe EB, eds. Handbook of Liver Disease 1st ed. Edinburgh: Churchill Livingstone 1998: 63-83
    Search in Google Scholar
  • 49 Neuberger J, Portmann B, Calne R, Williams R. Recurrence of autoimmune chronic active hepatitis following orthotopic liver grafting.  Transplantation . 1984;  37 363-365
    PubMedSearch in Google Scholar
  • 50 Wright H L, Bou-Abboud C F, Hassanein T. Disease recurrence and rejection following transplantation for autoimmune chronic active liver disease.  Transplantation . 1992;  53 136-139
    PubMedSearch in Google Scholar
  • 51 Birnbaum A H, Benkov K J, Pittman N S. Recurrence of autoimmune hepatitis in children after liver transplantation.  J Pediatr Gastroenterol Nutr . 1997;  25 20-25
    CrossrefPubMedSearch in Google Scholar
  • 52 Sempoux C, Horsmans Y, Lerut J. Acute lobular hepatitis as the first manifestation of recurrent autoimmune hepatitis after orthotopic liver transplantation.  Liver . 1997;  17 311-315
    PubMedSearch in Google Scholar
  • 53 Ahmed M, Mutimer D, Hathway M. Liver transplantation for autoimmune hepatitis: a 12 year experience.  Transpl Proc . 1997;  29 496
    PubMedSearch in Google Scholar
  • 54 Prados E, Cuervas-Mons V, De La Mata M. Outcome of autoimmune hepatitis after liver transplantation.  Transplantation . 1998;  66 1645-1650
    CrossrefPubMedSearch in Google Scholar
  • 55 Kerkar N, Hadzic N, Davies E T. De-novo autoimmune hepatitis after liver transplantation.  Lancet . 1998;  351 409-413
    CrossrefPubMedSearch in Google Scholar
  • 56 Gotz G, Neuhaus R, Bechstein W O. Recurrence of autoimmune hepatitis after liver transplantation.  Transpl Proc . 1999;  31 430-431
    PubMedSearch in Google Scholar
  • 57 Narumi S, Hakamada K, Sasaki M. Liver transplantation for autoimmune hepatitis: rejection and recurrence.  Transpl Proc . 1999;  31 1955-1956
    CrossrefPubMedSearch in Google Scholar
  • 58 Milkiewicz P, Hubscher S G, Skiba G. Recurrence of autoimmune hepatitis after liver transplantation.  Transplantation . 1999;  68 253-256
    CrossrefPubMedSearch in Google Scholar
  • 59 Ratziu V, Samuel D, Sebagh M. Long-term follow-up after liver transplantation for autoimmune hepatitis: evidence of recurrence of primary disease.  J Hepatol . 1999;  30 131-141
    CrossrefPubMedSearch in Google Scholar
  • 60 Sanchez-Urdazpal L, Czaja A J, van Hoek B. Prognostic features and role of liver transplantation in severe corticosteroid-treated autoimmune chronic active hepatitis.  Hepatology . 1992;  15 215-221
    PubMedSearch in Google Scholar